BONVIVA

For treatment of osteoporosis in post-menopausal women at increased risk of fracture 1,2... 66% of women preferred a once-monthly ibandronate regimen to a once-weekly alendronate regimen (p<0.0001) 3... The primary reason that patients chose ibandronate in the present study were that the once-monthly regimen fits better into their lifestyle and was easier to follow over a long period of time 3